This review highlights the physiological roles and potential therapeutic applications of KATP channel regulators in cardiovascular and smooth muscle disorders.
No takes yet. Share an insight, caveat, or question.
K channel openers merit selective-agent development for smooth muscle and cardiac disorders; leaves open clinical translation pending targeted trials.
Challinor-Rogers. et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: